CELLDEX THERAPEUTICS INC (CLDX)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for CLDX
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| CLDX | Director | 60 | ["President of CLC Consulting since 2008","Chief Commercial Officer at Medivation, Inc. from August 2011 to July 2014","Former Vice President of the Rheumatology Franchise at Johnson & Johnson","Former management and sales at Solvay Pharmaceuticals"] | ["Compensation and Organization Development","Science and Commercialization"] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| IBRX | Lead Independent Director | 60 | ["principal owner and president of CLC Consulting, LLC","chief commercial officer of Medivation, Inc.","Vice President, Strategic Commercial Group, of Health Care Systems, Inc.","worked at Janssen Biotech, Inc. in senior sales roles","board member of Celldex Therapeutics, Inc.","extensive experience with and knowledge of the healthcare industry","commercialization expertise","experience serving on boards of directors of public companies"] | ["Compensation","Nominating and Corporate Governance","Related Party Transaction","Audit","Special"] | 2026 |
Biography sourced from the proxy statement filing.
CHERYL L. COHEN, 60
CARIEER HIGHLIGHTS
Director since June 2022
CLC Consulting
President since 2008
PUBLIC BOARDS: 2
Medivation, Inc.
Chief Commercial Officer from August 2011 to July 2014, where she built the company's commercial organization and led her team to successfully launch the oncology drug, Xtandi
COMMITTEES: Compensation and Organization Development, Science and Commercialization
Johnson & Johnson
Former Vice President of the Rheumatology Franchise
EDUCATION: B.A. degree from Saint Joseph College
Solvay Pharmaceuticals
Former management and sales
Immunity Bio* (previously NantKwest)
Board of directors since 2019
MEI Pharma*
Board of directors from April 2020 to December 2022
Ignyte Acquisition Corp.
Board of directors from January 2021 to April 2022